Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. [electronic resource]
- Translational psychiatry Apr 2016
- e785 p. digital
Publication Type: Journal Article; Review
2158-3188
10.1038/tp.2016.50 doi
Comorbidity Diabetes Mellitus, Type 2--complications Humans Prolactin--metabolism Schizophrenia--complications